Related Experiment Video
Updated: Feb 4, 2026

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
Published on: January 6, 2023
Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol
Julian Kenyon1, Wai Liu2, Angus Dalgleish2
1The Old Brewery, Winchester Hants, U.K. jnkenyon@doveclinic.com.
Background/Aim:
Cannabinoids are widely used in the management of pain, nausea and cachexia in cancer patients. However, there has been no objective clinical evidence of any anticancer activity yet. The aim of this study was to assess the effects of pharmaceutical-grade synthetic cannabidiol on a range of cancer patients.
Patients And Methods:
We analysed the data routinely collected, as part of our treatment program, in 119 cancer patients over a four-year period.
Results:
Clinical responses were seen in 92% of the 119 cases with solid tumours including a reduction in circulating tumour cells in many cases and in other cases, a reduction in tumour size, as shown by repeat scans. No side-effects of any kind were observed when using pharmaceutical grade synthetic cannabidiol.
Conclusion:
Pharmaceutical-grade synthetic cannabidiol is a candidate for treating breast cancer and glioma patients.
More Related Videos
Related Concept Videos
Data Reporting and Recording
Pharmaceutical Equivalents
Graded Potential
Graded potentials fall into two categories: depolarizing and hyperpolarizing. Depolarizing graded potentials typically occur when sodium (Na+) or...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Types of Aggregate Grading
Well-graded aggregates include a complete range of necessary size fractions that fit together to create a dense matrix with minimal voids, represented by a smooth, continuous gradation curve. This type of grading ensures good...
Velocity of an Object

